Standout Papers

Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development 2013 2026 2017 2021 436
  1. Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development (2013)
    Qingjie Ding, Zhuming Zhang et al. Journal of Medicinal Chemistry

Immediate Impact

1 by Nobel laureates 9 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
54 intermediate papers

Works of Nan Jiang being referenced

Endoplasmic reticulum stress induced LOX‐1CD15+ polymorphonuclear myeloid‐derived suppressor cells in hepatocellular carcinoma
2017
Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development
2013
and 3 more

Author Peers

Author Last Decade Papers Cites
Nan Jiang 1015 1438 384 871 179 3.5k
Ming‐Shyen Yen 970 1698 393 707 121 4.7k
Kwon‐Ha Yoon 699 1177 630 626 156 3.9k
Günter Emons 665 2141 256 1497 242 7.0k
Marco Marchisio 794 2437 241 569 162 4.9k
Hideaki Takahashi 922 831 506 1305 221 3.4k
Tõru Nakamura 883 1234 651 871 211 3.8k
Riko Kitazawa 563 2673 788 1437 225 5.4k
Yoichi Mizutani 731 1235 297 508 128 3.0k
Niki J. Agnantis 732 1508 294 1356 177 4.0k
Sakan Maeda 750 2325 210 1258 186 4.7k

All Works

Loading papers...

Rankless by CCL
2026